Jessica Gregor, MS, CCC-SLP, BCS-S, Author at Dysphagia Cafe

1 POSTS 0 COMMENTS

Jessica is a Speech-Language Pathologist in the Department of Otolaryngology – Head and Neck Surgery at Mayo Clinic in Phoenix, Arizona with expertise in diagnostics and intervention of swallowing disorders in adults. She is board-certified through the American Board of Swallowing and Swallowing Disorders. Jessica also specializes in prevention, management, and rehabilitation of speech, jaw opening, breathing, and lymphatics in the oncology population, including alaryngeal speech and pulmonary optimization in total laryngectomees. She established the first Multidisciplinary Swallowing Clinic within the Mayo Clinic system with her ENT and GI colleagues for best collaborative care of complex dysphagia cases. Jessica obtained her Bachelor of Science in Speech & Hearing Science at the University of Illinois at Urbana-Champaign in 2008 and her Master of Science in Speech-Language Pathology at Rush University in Chicago, IL in 2010. She is a trainer for the McNeill Dysphagia Therapy Program as well as a clinical mentor for the Med SLP Ed and associated certification program. Follow Jessica on Instagram: @the_swallow_nerd

Multidisciplinary Swallow Clinic: Can I do it too?

Jessica Gregor, MS, CCC-SLP, BCS-S - September 18, 2023

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.